Immunitybio Stock Investor Sentiment
| IBRX Stock | USD 4.82 0.67 12.20% |
Slightly above 55% of Immunitybio's investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Immunitybio suggests that some traders are interested. Immunitybio's investor sentiment overview provides quick insight into current market opportunities from investing in Immunitybio. The current market sentiment, together with Immunitybio's historical and current headlines, can help investors time the market. In addition, many technical investors use Immunitybio stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Panic Vs Confidence
55
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Immunitybio's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Immunitybio.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentAcquiring |
Immunitybio stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Immunitybio daily returns and investor perception about the current price of Immunitybio as well as its diversification or hedging effects on your existing portfolios.
Immunitybio Historical Sentiment
Although Immunitybio's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Immunitybio, such as negative comments on social media and news outlets, may cause fear in the market and push Immunitybio's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Immunitybio.
Immunitybio |
Immunitybio Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Immunitybio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Immunitybio Historical Investor Sentiment
Investor biases related to Immunitybio's public news can be used to forecast risks associated with an investment in Immunitybio. The trend in average sentiment can be used to explain how an investor holding Immunitybio can time the market purely based on public headlines and social activities around Immunitybio. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Immunitybio's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Immunitybio and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Immunitybio news discussions. The higher the estimate score, the more favorable the investor's outlook on Immunitybio.
Immunitybio Maximum Pain Price across 2024-05-17 Option Contracts
Immunitybio's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Immunitybio close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Immunitybio's options.
Far too much social signal, news, headlines, and media speculation about Immunitybio that are available to investors today. That information is available publicly through Immunitybio media outlets and privately through word of mouth or via Immunitybio internal channels. However, regardless of the origin, that massive amount of Immunitybio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Immunitybio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Immunitybio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Immunitybio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Immunitybio alpha.
Immunitybio Performance against NYSE Composite
Price Growth (%) |
| Timeline |
1 | ImmunityBio Quality-of-Life Study in BCG-Unresponsive Bladder Cancer Trial Indicates Improved Physical Function in the 71 percent Complete Responders Suggesting... | 02/05/2024 |
2 | IBRX LAWSUIT ALERT Levi Korsinsky Notifies ImmunityBio, Inc. Investors of a Class Action Lawsuit and Upcoming ... - The Globe and Mail | 02/28/2024 |
3 | N-803 Combined with Natural Killer Cells Showed Potential to Reduce HIV Viral Load in HIV Positive Subjects Part of HIV Cure Study | 03/05/2024 |
4 | ImmunityBio Trading 9.3 percent Higher - MarketBeat | 03/08/2024 |
5 | IBRX Stock Earnings ImmunityBio Misses EPS, Beats Revenue for Q4 2023 | 03/20/2024 |
6 | Is Immunitybio Inc Stock a Smart Value - InvestorsObserver | 03/26/2024 |
7 | SG Americas Securities LLC Purchases 15308 Shares of ImmunityBio, Inc. - Defense World | 04/11/2024 |
8 | ImmunityBio files automatic mixed shelf | 04/17/2024 |
9 | FDA Approves ImmunityBios Bladder Cancer Drug, Stock Rallies | 04/23/2024 |
Check out Immunitybio Hype Analysis, Immunitybio Correlation and Immunitybio Performance. For more information on how to buy Immunitybio Stock please use our How to Invest in Immunitybio guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Complementary Tools for Immunitybio Stock analysis
When running Immunitybio's price analysis, check to measure Immunitybio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunitybio is operating at the current time. Most of Immunitybio's value examination focuses on studying past and present price action to predict the probability of Immunitybio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunitybio's price. Additionally, you may evaluate how the addition of Immunitybio to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
Is Immunitybio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunitybio. If investors know Immunitybio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunitybio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.15) | Revenue Per Share 0.001 | Quarterly Revenue Growth 0.904 | Return On Assets (0.52) |
The market value of Immunitybio is measured differently than its book value, which is the value of Immunitybio that is recorded on the company's balance sheet. Investors also form their own opinion of Immunitybio's value that differs from its market value or its book value, called intrinsic value, which is Immunitybio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunitybio's market value can be influenced by many factors that don't directly affect Immunitybio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunitybio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunitybio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunitybio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.